Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.

Akkoc Mustafayev FN, Liu DD, Gutierrez AM, Lewis JE, Ibrahim NK, Valero V, Booser DJ, Litton JK, Koenig K, Yu D, Sneige N, Arun BK

Open source

DOI: 10.4274/ejbh.galenos.2023.2023-7-3
Published: 2023 Oct
Container: European journal of breast health
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4274/ejbh.galenos.2023.2023-7-3,
  title = {Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.},
  author = {Akkoc Mustafayev FN and Liu DD and Gutierrez AM and Lewis JE and Ibrahim NK and Valero V and Booser DJ and Litton JK and Koenig K and Yu D and Sneige N and Arun BK},
  year = {2023},
  journal = {European journal of breast health},
  doi = {10.4274/ejbh.galenos.2023.2023-7-3},
  url = {https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3}
}

RIS

TY  - JOUR
TI  - Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
AU  - Akkoc Mustafayev FN
AU  - Liu DD
AU  - Gutierrez AM
AU  - Lewis JE
AU  - Ibrahim NK
AU  - Valero V
AU  - Booser DJ
AU  - Litton JK
AU  - Koenig K
AU  - Yu D
AU  - Sneige N
AU  - Arun BK
PY  - 2023
JO  - European journal of breast health
DO  - 10.4274/ejbh.galenos.2023.2023-7-3
UR  - https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3
ER  -

APA

FN, A. M., DD, L., AM, G., JE, L., NK, I., V, V., DJ, B., JK, L., K, K., D, Y., N, S., & BK, A. (2023). Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.. European journal of breast health. https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3

Source records

pubmed · retrieved 2026-09-26T06:05:29.992Z